Largest pharmaceutical companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 pharmaceutical companies ranked by net assets, at ZAR 1.49T, ahead of Johnson & Johnson (ZAR 1.41T) and Sanofi (ZAR 1.37T). Figures as of 18 Nov 2026, 18:07 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerZAR 1.49T
- Median
- ZAR 15.2B
- Combined market value
- ZAR 87.96T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | ZAR 1.49T | ZAR 2.78T | ZAR 486.99 | 0.88% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | ZAR 1.41T | ZAR 11.47T | ZAR 4,765.46 | 0.91% down | 38% up | ||
| 3 | SanofiSNY · Health Care | ZAR 1.37T | ZAR 1.96T | ZAR 817.71 | 0.31% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | ZAR 907.8B | ZAR 5.91T | ZAR 2,398.78 | 3.04% down | 51% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | ZAR 899.6B | ZAR 3.13T | ZAR 1,807.99 | 0.06% up | 17% down | ||
| 6 | AstraZenecaAZN · Health Care | ZAR 839.8B | ZAR 4.81T | ZAR 3,102.94 | 1.35% down | 2% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | ZAR 802.9B | ZAR 1.18T | ZAR 369.55 | 1.04% down | 54% up | ||
| 8 | NovartisNVS · Health Care | ZAR 796.1B | ZAR 5.09T | ZAR 2,694.82 | 1.87% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 539.4B | ZAR 1.69T | ZAR 16,366.86 | 0.97% down | 36% up | ||
| 10 | Novo NordiskNVO · Health Care | ZAR 496.9B | ZAR 3.02T | ZAR 684.32 | 2.57% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | ZAR 457.9B | ZAR 21.46T | ZAR 24,086.85 | 1.40% down | 35% up | ||
| 12 | GSKGSK · Health Care | ZAR 375.1B | ZAR 1.69T | ZAR 843.43 | 0.74% down | 6% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 322.1B | ZAR 2.35T | ZAR 9,283.81 | 0.71% up | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | ZAR 318.8B | ZAR 2.12T | ZAR 1,038.43 | 1.92% down | 34% up | ||
| 15 | ViatrisVTRS · Health Care | ZAR 253.9B | ZAR 409B | ZAR 356.78 | 1.10% up | 96% up | ||
| 16 | Royalty PharmaRPRX · Health Care | ZAR 167.6B | ZAR 687.8B | ZAR 1,196.24 | 0.93% up | 78% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | ZAR 136.5B | ZAR 849.9B | ZAR 728.41 | 0.96% down | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | ZAR 122.5B | ZAR 427.7B | ZAR 10,043.45 | 0.36% down | 23% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | ZAR 113B | ZAR 232.4B | ZAR 464.98 | 4.24% up | 20% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 105B | ZAR 202.5B | ZAR 1,045.59 | 3.55% up | 11% up | ||
| 21 | GrifolsGRFS · Health Care | ZAR 100.9B | ZAR 99.5B | ZAR 146.17 | 1.85% down | 1% up | ||
| 22 | GenmabGMAB · Health Care | ZAR 100.9B | ZAR 548B | ZAR 888.74 | 0.88% down | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | ZAR 78.1B | ZAR 481.9B | ZAR 665.08 | 0.44% down | 90% up | ||
| 24 | BeOne MedicinesONC · Health Care | ZAR 75.3B | ZAR 799.3B | ZAR 6,997.28 | 1.88% down | 17% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | ZAR 74.5B | ZAR 272.8B | ZAR 4,249.48 | 2.30% up | 37% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 69.2B | ZAR 216.3B | ZAR 259.46 | 1.66% up | 5% up | ||
| 27 | ZoetisZTS · Health Care | ZAR 57.5B | ZAR 597B | ZAR 1,469.33 | 1.99% up | 29% down | ||
| 28 | AlkermesALKS · Health Care | ZAR 31.4B | ZAR 135.9B | ZAR 808.65 | 3.10% up | 58% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | ZAR 17.6B | ZAR 103.8B | ZAR 5,189.20 | 2.35% up | 43% up | ||
| 30 | Legend BiotechLEGN · Health Care | ZAR 17.3B | ZAR 54.4B | ZAR 280.25 | 0.81% up | 42% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | ZAR 15.2B | ZAR 148.1B | ZAR 5,297.83 | 0.64% up | 61% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 13.6B | ZAR 348.9B | ZAR 2,605.26 | 3.53% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | ZAR 13.3B | ZAR 110.8B | ZAR 2,727.09 | 0.20% up | 31% up | ||
| 34 | InsmedINSM · Health Care | ZAR 12.8B | ZAR 457.6B | ZAR 2,086.00 | 0.80% down | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | ZAR 12.3B | ZAR 158.2B | ZAR 1,666.14 | 2.92% up | 286% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | ZAR 11.4B | ZAR 146.3B | ZAR 182.92 | 0.66% down | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | ZAR 11.2B | ZAR 171.9B | ZAR 1,137.22 | 5.09% up | 107% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | ZAR 11.2B | ZAR 128.9B | ZAR 1,177.60 | 2.61% down | 8% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | ZAR 11B | ZAR 84.3B | ZAR 484.57 | 0.83% up | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | ZAR 10.6B | ZAR 141.3B | ZAR 2,164.35 | 0.60% up | 46% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 10.4B | ZAR 162.8B | ZAR 7,007.12 | 3.78% down | 24% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | ZAR 9.8B | ZAR 128.8B | ZAR 1,639.61 | 0.10% down | 126% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | ZAR 9B | ZAR 79.1B | ZAR 722.46 | 0.42% down | 88% up | ||
| 44 | ABIVAXABVX · Health Care | ZAR 8.7B | ZAR 126.5B | ZAR 1,445.04 | 1.99% up | 27% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | ZAR 8.5B | ZAR 84.6B | ZAR 1,501.51 | 0.03% up | 113% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | ZAR 8.4B | ZAR 79B | ZAR 474.22 | 1.93% up | 64% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | ZAR 8.1B | ZAR 113.3B | ZAR 1,670.97 | 0.53% up | 241% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | ZAR 8B | ZAR 106.2B | ZAR 751.02 | 1.23% up | 10% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | ZAR 5.7B | ZAR 68.3B | ZAR 498.89 | 1.60% down | 169% up | ||
| 50 | ErascaERAS · Health Care | ZAR 5.6B | ZAR 80.2B | ZAR 228.48 | 4.68% down | 403% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | ZAR 5.4B | ZAR 104.3B | ZAR 1,596.94 | 0.64% up | 31% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 2.4B | ZAR 142.2B | ZAR 2,050.88 | 1.92% up | 13% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | ZAR 2B | ZAR 84.5B | ZAR 880.01 | 0.21% down | 44% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | ZAR 1.5B | ZAR 121.2B | ZAR 2,303.52 | 1.81% down | 7% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -ZAR 1.2B | ZAR 132.5B | ZAR 380.34 | 4.36% up | 83% up | ||
| 56 | VeradermicsMANE · Health Care | -ZAR 2.1B | ZAR 90.2B | ZAR 2,138.63 | 1.36% down | 233% up | ||
| 57 | Ascendis PharmaASND · Health Care | -ZAR 3.1B | ZAR 307.9B | ZAR 4,693.33 | 0.29% up | 28% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -ZAR 3.5B | ZAR 87B | ZAR 1,041.79 | 0.02% up | 20% down | ||
| 59 | CytokineticsCYTK · Health Care | -ZAR 11.4B | ZAR 124.4B | ZAR 892.87 | 0.17% up | 20% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -ZAR 36B | ZAR 262.6B | ZAR 1,348.19 | 1.73% up | 17% up | ||
| 61 | AbbVieABBV · Health Care | -ZAR 56.4B | ZAR 8.79T | ZAR 4,975.13 | 1.54% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2568 ZAR).
Questions and answers
Which pharmaceutical companies rank first by net assets?
Pfizer (ZAR 1.49T), Johnson & Johnson (ZAR 1.41T) and Sanofi (ZAR 1.37T) are the top three of the 61 pharmaceutical companies ranked by net assets as of 18 Nov 2026, 18:07 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by net assets.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by net assets have a combined market value of ZAR 87.96T as of 18 Nov 2026, 18:07 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.